Category: Include on Menu

  • CMS Energy Shares Decline After Second-Quarter Earnings Miss

    CMS Energy Shares Decline After Second-Quarter Earnings Miss

    CMS Energy (NYSE:CMS) reported weaker-than-expected second-quarter results on Tuesday, missing Wall Street estimates for both earnings and revenue, although the utility reaffirmed its full-year outlook and outlined strategic changes aimed at simplifying its business. Shares fell 3.07% in pre-market trading following the earnings release. Adjusted earnings per share came in at $0.37, well below the…

  • ProMIS Neurosciences Shares Climb on Positive Interim Alzheimer’s Trial Safety Results

    ProMIS Neurosciences Shares Climb on Positive Interim Alzheimer’s Trial Safety Results

    ProMIS Neurosciences Inc. (NASDAQ:PMN) shares gained 13% on Tuesday after the company released encouraging six-month interim safety and biomarker data from its ongoing PRECISE-AD Phase 1b study evaluating PMN310 in patients with Alzheimer’s disease. The clinical-stage biotechnology company reported favourable blinded interim findings, highlighting a strong safety profile and biomarker trends that support continued development…

  • Pentair Shares Drop After Revenue Miss Overshadows Earnings Beat

    Pentair Shares Drop After Revenue Miss Overshadows Earnings Beat

    Pentair plc (NYSE:PNR) reported second-quarter results on Tuesday that exceeded earnings expectations, but weaker-than-expected revenue and a soft near-term outlook weighed on investor sentiment, sending the company’s shares lower in pre-market trading. Shares of the water treatment and flow solutions company fell 5.03% following the earnings release. Adjusted earnings per share came in at $1.14,…

  • Altimmune Shares Jump After Positive Phase 2 Alcohol Use Disorder Trial Results

    Altimmune Shares Jump After Positive Phase 2 Alcohol Use Disorder Trial Results

    Altimmune Inc. (NASDAQ:ALT) shares climbed 18% on Tuesday after the biotechnology company reported positive topline data from its Phase 2 RECLAIM study evaluating pemvidutide as a treatment for alcohol use disorder. The trial successfully achieved its primary endpoint, demonstrating a statistically significant reduction in heavy drinking days compared with placebo. Pemvidutide Meets Primary and Secondary…

  • Corning Shares Slide Despite Second-Quarter Earnings Beat as Guidance Disappoints

    Corning Shares Slide Despite Second-Quarter Earnings Beat as Guidance Disappoints

    Corning Incorporated (NYSE:GLW) reported better-than-expected second-quarter earnings on Tuesday, but investors focused on weaker-than-anticipated guidance for the third quarter, sending the specialty glass and materials manufacturer’s shares down 11.2%. The company posted adjusted earnings per share of $0.78, exceeding the analyst consensus estimate of $0.75. Quarterly revenue reached $4.74 billion, ahead of expectations of $4.62…

  • TransUnion Tops Second-Quarter Expectations and Increases Full-Year Forecast

    TransUnion Tops Second-Quarter Expectations and Increases Full-Year Forecast

    TransUnion (NYSE:TRU) reported stronger-than-expected second-quarter results on Tuesday, surpassing Wall Street forecasts for both earnings and revenue while raising its outlook for the full year on the back of continued growth across its domestic and international businesses. Despite the earnings beat, shares slipped 0.96% in pre-market trading following the announcement. Adjusted earnings per share rose…

  • Centene Raises Full-Year Outlook After Strong Second-Quarter Earnings Beat

    Centene Raises Full-Year Outlook After Strong Second-Quarter Earnings Beat

    Centene Corporation (NYSE:CNC) reported better-than-expected second-quarter results on Tuesday, delivering earnings and revenue that comfortably exceeded Wall Street forecasts as improved performance across its Medicare and Commercial businesses supported a stronger full-year outlook. Shares of the health insurer rose 3.04% in pre-market trading following the earnings announcement. Adjusted earnings per share came in at $2.51,…

  • AllianceBernstein Matches Earnings Forecasts While Revenue Misses Expectations

    AllianceBernstein Matches Earnings Forecasts While Revenue Misses Expectations

    AllianceBernstein Holding L.P. (NYSE:AB) reported second-quarter results on Tuesday that met earnings expectations but came in slightly below Wall Street forecasts on revenue, as the asset manager continued to benefit from stronger client inflows and record assets under management. The company’s stock edged 0.18% higher in after-hours trading following the earnings release. Adjusted earnings per…

  • Axalta Shares Gain After Second-Quarter Earnings and Revenue Top Expectations

    Axalta Shares Gain After Second-Quarter Earnings and Revenue Top Expectations

    Axalta Coating Systems Ltd. (NYSE:AXTA) reported stronger-than-expected second-quarter results on Tuesday, with earnings and revenue both exceeding Wall Street forecasts as the coatings manufacturer delivered record profitability and healthy cash generation. Shares of the company rose 2.13% in pre-market trading following the earnings announcement. Adjusted earnings per share came in at $0.72, comfortably ahead of…

  • INNIO Shares Decline Despite Revenue and Earnings Beat in Second Quarter

    INNIO Shares Decline Despite Revenue and Earnings Beat in Second Quarter

    INNIO N.V. (NASDAQ:INIO) reported second-quarter results that exceeded Wall Street expectations on Tuesday, but the company’s shares moved lower after the earnings release despite strong revenue growth and record order momentum. Shares of the distributed energy solutions provider fell 2.86% following the announcement. The company reported adjusted earnings per share of $0.08, ahead of analyst…